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A total of 26 strains of Vibrio cholerae, including members of the O1, O139, and non-O1, non-O139
serogroups from both clinical and environmental sources, were examined for the presence of genes encoding
cholera toxin (ctxA), zonula occludens toxin (zot), accessory cholera enterotoxin (ace), hemolysin (hlyA),
NAG-specific heat-stable toxin (st), toxin-coregulated pilus (tcpA), and outer membrane protein (ompU), for
genomic organization, and for the presence of the regulatory protein genes tcpI and toxR in order to determine
relationships between epidemic serotypes and sources of isolation. While 22 of the 26 strains were hemolytic
on 5% sheep blood nutrient agar, all strains were PCR positive for hlyA, the hemolysin gene. When multiplex
PCR was used, all serogroup O1 and O139 strains were positive for tcpA, ompU, and tcpI. All O1 and O139
strains except one O1 strain and one O139 strain were positive for the ctxA, zot, and ace genes. Also, O1 strain
VO3 was negative for the zot gene. All of the non-O1, non-O139 strains were negative for the ctxA, zot, ace, tcpA,
and tcpI genes, and all of the non-O1, non-O139 strains except strain VO26 were negative for ompU. All of the
strains except non-O1, non-O139 strain VO22 were PCR positive for the gene encoding the central regulatory
protein, toxR. All V. cholerae strains were negative for the NAG-specific st gene. Of the nine non-ctx-producing
strains of V. cholerae, only one, non-O1, non-O139 strain VO24, caused fluid accumulation in the rabbit ileal
loop assay. The other eight strains, including an O1 strain, an O139 strain, and six non-O1, non-O139 strains,
regardless of the source of isolation, caused fluid accumulation after two to five serial passages through the
rabbit gut. Culture filtrates of all non-cholera-toxigenic strains grown in AKI media also caused fluid accu-
mulation, suggesting that a new toxin was produced in AKI medium by these strains. Studies of clonality
performed by using enterobacterial repetitive intergenic consensus sequence PCR, Box element PCR, amplified
fragment length polymorphism (AFLP), and pulsed-field gel electrophoresis (PFGE) collectively indicated that
the V. cholerae O1 and O139 strains had a clonal origin, whereas the non-O1, non-O139 strains belonged to
different clones. The clinical isolates closely resembled environmental isolates in their genomic patterns.
Overall, there was an excellent correlation among the results of the PCR, AFLP, and PFGE analyses, and
individual strains derived from clinical and environmental sources produced similar fingerprint patterns.
From the results of this study, we concluded that the non-cholera-toxin-producing strains of V. cholerae,
whether of clinical or environmental origin, possess the ability to produce a new secretogenic toxin that is
entirely different from the toxin produced by toxigenic V. cholerae O1 and O139 strains. We also concluded that
the aquatic environment is a reservoir for V. cholerae O1, O139, non-O1, and non-O139 serogroup strains.
Vibrio cholerae is a natural inhabitant of the aquatic envi-
ronment (9, 12, 15, 21, 24, 31, 37). This vibrio species not only
survives in riverine, estuarine, and coastal waters around the
world but also lives in association with crustacean copepods,
such as Acartia tonsa and Gerris spinolae, and with aquatic
plants, either in the viable and culturable state or in the viable
but nonculturable state (13, 25, 30, 32, 33, 36, 49, 53, 66, 70).
Since this human pathogen is primarily an inhabitant of the
aquatic environment, water plays an important role in the
transmission and epidemiology of cholera (19, 38, 72). How-
ever, the epidemiological impact of environmental V. cholerae
strains is not clearly understood, since the majority of strains
isolated from the environment do not produce cholera toxin
and lack not only the virulence gene cassette (45, 64) for
cholera toxin but also zonula occludens toxin and accessory
cholera enterotoxin. In addition, environmental vibrios lack
the toxin-coregulated pilus (TCP) that is recognized as a sig-
nificant factor in the pathogenicity of toxigenic strains of V.
cholerae serogroups O1 and O139.
Strains of V. cholerae belonging to serogroup O1 biotype El
Tor and serogroup O139 have been described as causative
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agents of diarrhea (1, 10, 34, 42, 55). Furthermore, results of
genetic and phenotypic characterizations of such strains indi-
cate that in order to cause diarrhea, they require genes for
cholera toxin, the colonization TCP, and the central regulatory
protein ToxR (27, 29, 46, 50, 76). However, nontoxigenic
strains isolated from the environment and lacking the virulence
gene cassette have been reported to evoke the secretory re-
sponse in the ligated rabbit ileal loop assay (62, 63). Nontoxi-
genic O1 biotype El Tor strains have also been isolated from
cases of diarrhea (11, 60).
V. cholerae non-O1, non-O139 strains are recognized as
causative agents of sporadic and localized outbreaks, and the
diarrhea caused by these strains is sometimes characterized by
blood and mucous (8, 61). However, these strains continue to
be considered of negligible significance, since they have been
associated with illness only in a low percentage of patients
hospitalized with secretory diarrhea (52). While analyzing the
nucleotide sequence of asd genes in V. cholerae strains, Kara-
olis et al. (43) demonstrated that the sixth- and seventh-pan-
demic strains and United States Gulf Coast V. cholerae O1
isolates may have been derived from nontoxigenic strains and
postulated that horizontal gene transfer occurred in V. chol-
erae, which resulted in the emergence of a new pathogenic
strain. Furthermore, V. cholerae non-O1 serogroups have been
reported to be involved in the emergence of a newer variant of
V. cholerae; this hypothesis is supported by the genesis of V.
cholerae O139, a serogroup believed to have evolved by hori-
zontal gene transfer from serogroup O1 to a non-O1 serogroup
(7).
Amplified fragment length polymorphism (AFLP), pulsed-
field gel electrophoresis (PFGE), and PCR methods have been
used in epidemiological investigations and also to study relat-
edness among bacterial strains in order to trace the origin and
geographical distribution of V. cholerae (40, 69, 73, 75). It is
accepted that cholera is a waterborne disease, but there is no
molecular evidence to prove that strains causing human infec-
tions belong to the same clones as those found in aquatic
environments. To answer this vexing question, we examined a
set of strains belonging to O1, O139, and non-O1, non-O139
serogroups, including both clinical and environmental isolates,
to determine whether virulence and regulatory genes were
present and to compare their genomic organizations.
MATERIALS AND METHODS
Bacterial strains. A total of 26 strains of V. cholerae were included in this
study. Seven strains were serogroup O1 strains (four clinical strains and three
environmental strains), eight strains were serogroup O139 strains (four strains
each from clinical and environmental sources), and seven strains were non-O1,
non-O139 strains (two clinical isolates and five environmental isolates) from
laboratory stocks and had been identified previously by using standard bacteri-
ological methods (77). Four additional isolates of V. cholerae O139, including
reference strain ATCC 51394 (5 MO45), provided by G. B. Nair, National
Institute of Cholera and Enteric Diseases, Calcutta, India, were also included in
the study. All isolates were examined for the oxidase reaction, and the identities
of the V. cholerae O1 strains were confirmed by serogrouping by using growth
from triple sugar iron agar slants with polyvalent O1 and monospecific Inaba and
Ogawa antisera. V. cholerae strains which did not agglutinate with O1 antiserum
were checked with monoclonal O139 antiserum supplied by the WHO Regional
Office of South-East Asia, New Delhi, India. V. cholerae strains which did not
agglutinate with either O1 or O139 antisera were assumed to belong to non-O1,
non-O139 serogroups. The sources, years of isolation, and geographical sites of
isolation of the strains are listed in Table 1. All strains were maintained in
peptone agar stab cultures and did not undergo more than two subcultures prior
to testing in this study.
Hemolysis. Strains of V. cholerae were grown in brain heart infusion broth
(Difco) for 3 h and were subsequently streaked on 5% sheep blood nutrient agar
plates. After overnight incubation at 37°C, colonies were examined for hemolysis
on blood agar.
Preparation of culture filtrates. Culture filtrates of all nine non-cholera-toxin-
producing strains, including an O1 strain and an O139 serogroup representative,
were prepared by the method of Sanyal et al. (63). Briefly, 10-ml portions of AKI
medium or brain heart infusion broth in 50-ml conical flasks were inoculated with
approximately five colonies from an overnight nutrient agar plate culture. The
flasks were incubated at 37°C in a water bath for 16 to 18 h with shaking at 80 to
120 oscillations per min. The cultures were centrifuged at 22,000 3 g for 20 min,
the supernatants were filtered through membrane filters (pore size, 0.22 mm;
Millipore), and the filtrates were stored in small volumes at 4°C.
Ileal loop test and passage through rabbit ileal loops. Cultures and culture
filtrates of non-cholera-toxigenic V. cholerae strains were tested for enterotoxin
production in adult New Zealand and albino rabbits by the method of De and
Chatterje (17). The strains were grown in peptone water for 3 to 4 h, diluted
10-fold in the same medium, and inoculated into rabbit ileal loops by using 1-ml
portions of preparations containing 105 to 106 CFU/ml. V. cholerae toxigenic
strain 569B grown in peptone water and uninoculated, sterile peptone water
served as positive and negative controls, respectively. Culture filtrates of all
strains prepared in AKI medium were tested by the same method by using 1-ml
inocula. Each test was done in two rabbits; six to eight 8- to 10-cm loops were
ligated in each rabbit, and the interloop length was 2 to 4 cm. The rabbits were
sacrificed after 18 h.
V. cholerae strains that caused little or no fluid accumulation in the initial tests
were passaged through the rabbit gut by using the method of Sanyal et al. (63).
Briefly, each strain was recovered from the ileal loops on nutrient agar plates,
and following overnight incubation approximately five colonies were inoculated
into peptone water and incubated at 37°C for 3 to 4 h. Approximately 1 ml of
diluted culture was again inoculated into rabbit ileal loops. This process was
continued until unequivocal positive responses were obtained.
Ouchterlony immunodiffusion. Ouchterlony immunodiffusion tests were per-
formed by using concentrated (103) culture filtrates of test strains prepared in
AKI medium, and the new anti-cholera toxin serum. Cholera toxin gene-negative
V. cholerae strain X-392, which has been reported to produce the new cholera
toxin (62, 63), was obtained from J. B. Kaper of the Center for Vaccine Devel-
opment, University of Maryland, College Park, and was used to prepare anti-
serum against the new cholera toxin in purified form as described previously (67).
DNA isolation. Chromosomal DNA was extracted from each of the V. cholerae
strains by the cetyltrimethylammonium bromide method, as described by Aus-
ubel et al. (4). The purity of the DNA was assayed with a Beckman DU 640
spectrophotometer by using automatic calculation of the ratio of optical densities
at 260 and 280 nm.
Multiplex PCR assay. A multiplex PCR assay was performed (22, 65, 74; G. R.
Matte, M. H. Matte, J. Chun, A. Huq, and R. R. Colwell, submitted for publi-
cation) in order to determine the presence of toxin genes ctxA, zot, ace, st, hlyA,
tcpA, and ompU. In addition, all strains were examined for the presence of
regulatory genes for TCP expression (tcpI) and the central regulatory protein
(toxR). The primers used in this study and the expected amplicon sizes are listed
in Table 2. PCR was performed with a PTC-200 thermal cycler (MJ Research,
Inc., Waltham, Mass.). The instrument was programmed as follows: initial de-
naturation at 94°C for 2 min, followed by 30 cycles consisting of 94°C for 1 min,
60°C for 1 min, and 72°C for 1 min and a final extension step of 72°C for 10 min.
For the tcpI gene, extension was at 72°C for 3 min and all of the other steps were
the same as those described above. The amplification program for the st and ace
genes began with denaturation at 94°C for 1 min, which was followed by 29 cycles
consisting of 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s and a final extension
step of 72°C for 5 min. V. cholerae O139 strain MO45 (5 ATCC 51394) was used
as the PCR positive control for ctxA, zot, ace, tcpA, ompU, tcpI, and toxR. ST1
V. cholerae non-O1, non-O139 strain 618, provided by A. C. P. Vicente, Depart-
ment of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil,
was used as a positive control for the st gene. Amplified products were separated
on a 1% agarose gel, stained with ethidium bromide, and photographed.
Genomic fingerprinting by ERIC- and BOX-PCR. Enterobacterial repetitive
intergenic consensus sequence PCR (ERIC-PCR) was performed as described
by Rivera et al. (56) by using two oligonucleotide primers (59-ATGTAAGCTC
CTGGGGATTCAC-39 and 59-AAGTAAGTGACTGGGGTGAGCG-39). Box
elements PCR (BOX-PCR) was performed as described by Martin et al. (48) by
using a single oligonucleotide primer (59-CTACGGCAAGGCGACGCTGACG-
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39). The amplicons were electrophoresed in 1.8% agarose at 60 V for 6 h and
stained with SYBR Green I (FMC BioProducts, Rockland, Maine). The DNA
band patterns were digitized with a Bio-Imager (Molecular Dynamics) and sub-
jected to a fingerprint analysis. A 1-kb molecular size ladder (GIBCO-BRL,
Gaithersburg, Md.) was included on each gel.
AFLP fingerprinting. All AFLP procedures were performed as described by
Janssen et al. (40), with the minor modifications for V. cholerae described by
Jiang et al. (41). Briefly, 1 mg of DNA was double digested with restriction
enzymes TaqI and ApaI. Following digestion, adapters were added to final
concentrations of 0.4 mM for TaqI adapters (59-GACGATGAGTCCTGAC-39
and 39-TACTCAGGACTGGC-59) and 0.04 mM for ApaI adapters (59-TCGTA
GACTGCGTACAGGCC-39 and 39-CATCTGACGCATGT-59). Ligation reac-
tions were performed at 16°C overnight. Ligated template DNA was purified,
stored in Tris-EDTA buffer (10 mM Tris-HCl [pH 8.0], 0.1 mM EDTA [pH 8.0])
at 220°C, and used for PCR amplification within 48 h.
PCR was performed as described by Janssen et al. (40) by using primers A01
(59-GACTGCGTACAGGCCCA-39) and T01 (59-CGATGAGTCCTGACCGA
A-39). Prior to PCR, primer T01 was end labeled with [g-33P]ATP. Two micro-
liters of template DNA was used for amplification in a total reaction volume of
25 ml. Amplification products were separated on 5% denaturing polyacrylamide
and exposed to X-ray film (Kodak Inc.). Autoradiographs were digitized for
fingerprint analysis.
PFGE analysis. Intact genomic DNA was prepared by the method of Majum-
der et al. (47), with modifications. Briefly, vibrios were grown in Luria broth
(Difco) overnight at 37°C. Cells were harvested and washed twice with 10 mM
Tris-HCl (pH 7.6) buffer containing 1 M NaCl and suspended at a concentration
of 108 CFU/ml in the same buffer. Agarose plugs were prepared by mixing equal
volumes of the cell suspension and molten 1% agar (In Cert agarose; FMC
BioProducts). Cells were lysed in the plugs and stored in 5 ml of buffer containing
10 mM Tris-HCl (pH 8.0) and 50 mM EDTA (pH 8.0) at 4°C until they were
used.
Prior to restriction digestion, plugs containing genomic DNA were washed
twice (30 min each) in 10 volumes of buffer containing 10 mM Tris-HCl (pH 7.5)
and 1 mM EDTA. Digestion with SfiI (GIBCO-BRL) was carried out at 50°C for
16 h in a solution containing 100 mg of bovine serum albumin per ml by using 40
U of enzyme per plug.
PFGE was carried out with a CHEF Mapper System (Bio-Rad, Hercules,
Calif.) in 0.53 TBE buffer containing 0.1% (vol/vol) 100 mM thiourea. Electro-
phoresis was performed at 6 V/cm and 14°C at a field angle of 120° by using 1.2%
SeaKem GTG agarose gels (FMC BioProducts). The pulse time was ramped
from 2.98 to 54.17 s over 26.56 h. A lambda DNA ladder (Bio-Rad) was used as
the molecular weight standard. Following electrophoresis, the gels were stained
with SYBR Green I (Molecular Probes Inc., Eugene, Oreg.), the DNA band
patterns were imaged with a Bio-Image analyzer (Molecular Dynamics), and the
fingerprints were analyzed.
Analysis of fingerprint patterns. Digital images of ERIC-PCR, BOX-PCR,
AFLP, and PFGE fingerprint patterns were analyzed by using Molecular Fin-
gerprinting Analyst (Bio-Rad) as recommended by the manufacturer and were
graphically represented as dendrograms.
RESULTS
Twenty-two V. cholerae strains, including both clinical and
environmental strains, were hemolytic on 5% sheep blood nu-
trient agar (Table 3). Although two O1 strains (VO3 and VO5)
and two O139 strains (CO594 and VO17) were negative for
hemolysis, they were PCR positive, like all of the other strains,
for the genes representing the El Tor fragment for hemolysin
(hlyA). In addition, except for two of the non-O1, non-O139
isolates (VO23 and VO28), all strains were also PCR positive
for the genes encoding the classical fragment of hemolysin
(Table 3).
Of the nine non-cholera-toxin-producing strains, only one
environmental isolate belonging to the non-O1, non-O139 se-
rogroup (VO24) caused fluid accumulation (range, 0.5 to 0.9
TABLE 1. V. cholerae strains of the O1, O139, and non-O1, non-O139 serogroups included in this study
Strain Place of isolation Source Year of isolation
V. cholerae O1 biotype E1 Tor strains
VO1 Orissa, India Diarrheal patient 1969
VO2 Varanasi, India Diarrheal patient 1976
VO13 Varanasi, India Diarrheal patient 1989
VO3 Varanasi, India Diarrheal patient 1990
VO4 Varanasi, India River water 1986
VO5 Varanasi, India River water 1988
VO7 Varanasi, India River water 1988
V. cholerae O139 strains
MO45a Madras, India Diarrheal patient 1992
CO594 Calcutta, India Diarrheal patient 1992
CO766 Calcutta, India Diarrheal patient 1992
CO788 Calcutta, India Diarrheal patient 1992
VO12 Varanasi, India Diarrheal patient 1994
VO14 Varanasi, India Diarrheal patient 1993
VO15 Varanasi, India Diarrheal patient 1993
VO16 Varanasi, India Diarrheal patient 1994
VO17 Varanasi, India Eichhornia crassipes 1992
VO18 Varanasi, India Eichhornia crassipes 1992
VO19 Varanasi, India River water 1992
VO20 Varanasi, India Hand pump 1992
V. cholerae non-O1, non-O139 strains
VO22 Varanasi, India Diarrheal patient 1979
VO23 Varanasi, India Diarrheal patient 1979
VO24 Varanasi, India River water 1986
VO25 Varanasi, India River water 1988
VO26 Varanasi, India River water 1988
VO27 Varanasi, India River water 1986
VO28 Varanasi, India River water 1986
a V. cholerae O139 reference strain MO45 (5 ATCC 51394).
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ml/cm) in the initial rabbit ileal loop test. However, other
strains, including an O1 strain, an O139 strain, and six non-O1,
non-O139 isolates from clinical sources, caused fluid accumu-
lation after two to five serial passages through the rabbit gut,
and the amount of fluid accumulated ranged from 0.5 to 1.1
ml/cm. Culture filtrates of all strains prepared in brain heart
infusion broth and AKI medium also caused accumulation of
fluid at volumes similar to those caused by the whole cells.
When concentrated culture filtrates of cholera toxin gene-
negative V. cholerae O1 strain X-392 and non-cholera-toxin-
producing V. cholerae non-O1, non-O139 strains were tested by
gel diffusion, one strain (VO26) produced a precipitin band
against new cholera toxin antiserum, showing a reaction of
identity, whereas the other strains showed reactions of partial
identity (data not shown) (Table 3).
Based on the results of the multiplex PCR, all V. cholerae O1
and O139 strains yielded positive results for tcpA, tcpI, and
ompU, and one isolate each of V. cholerae O1 (VO1) and V.
cholerae O139 (CO788) gave negative results for the ctxA, zot,
and ace genes. Moreover, O1 strain VO3 was negative for the
zot gene. However, all V. cholerae non-O1, non-O139 strains
yielded negative results for ctxA, zot, ace, and tcpA, and VO26
gave a positive result for ompU. Further analysis showed that
all non-O1, non-O139 strains were also PCR negative for the
gene encoding tcpI, which negatively regulates expression of
tcp (Table 3). All V. cholerae strains were also negative for the
NAG-specific st gene. However, except for one non-O1, non-
O139 strain (VO22), all of the isolates were positive as deter-
mined by PCR for the gene encoding the central regulatory
protein, ToxR, which coordinates regulation of expression of
the dynamic core genetic element, including TCP and outer
membrane protein (OMP).
Genetic relatedness analyses of the clinical and environmen-
tal strains of V. cholerae performed by ERIC-PCR, BOX-PCR,
AFLP, and PFGE methods proved to be interesting. ERIC-
PCR of genomic DNA from the various V. cholerae strains
yielded a total of 16 fingerprints with sizes ranging between
0.18 and 4.0 kb, as shown in Fig. 1. Two of the seven O1
isolates, one clinical strain (VO3) and one environmental
strain (VO7), yielded similar fingerprints. Similarly, 3 of the 12
O139 serogroup strains, both clinical (VO12 and VO15) and
environmental (VO20), yielded identical PCR profiles; a non-
ctx-producing strain, CO788, yielded closely related finger-
prints. The other O1 and O139 serogroup strains produced
different fingerprints. A number of V. cholerae O1 and O139
strains had similar PCR profiles. However, they differed from
each other by the presence of an analogous fragment that was
approximately 0.29 kb long. When the seven V. cholerae non-
O1, non-O139 strains were examined, clinical isolate VO22
and environmental isolate VO25 produced similar PCR pro-
files, clinical isolate VO23 and environmental isolate VO27
produced similar PCR profiles, and environmental isolates
VO24 and VO28 strains produced similar PCR profiles.
As shown in Fig. 2, BOX-PCR of genomic DNA from var-
ious V. cholerae strains resulted in amplification of multiple
fragments of DNA that ranged from 0.29 to 6.0 kb long. All of
TABLE 2. Sequences of primers used for detection of selected virulence and regulatory genes
Target Nucleotide sequence (59-39) Directiona Ampliconsize (bp)
Reference, biotype, and/or
serotype
ctxA CGGGCAGATTCTAGACCTCCTG F 564 22
CGATGATCTTGGAGCATTCCCAC R
zot TCGCTTAACGATGGCGCGTTTT F 947 Matte et al.b
AACCCCGTTTCACTTCTACCCA R
ace TAAGGATGTGCTTATGATGGACACCC F 289 65
CGTGATGAATAAAGATACTCATAGG R
st GAGAAACCTATTCATTGC F 216 74
GCAAGCTGGATTGCAAC R
ompU ACGCTGACGGAATCAACCAAAG F 869 Matte et al.b
GCGGAAGTTTGGCTTGAAGTAG R
tcpA CACGATAAGAAAACCGGTCAAGAG F
TTACCAAATGCAACGCCGAATG R 620 Matte et al.; classicalb,c
CGAAAGCACCTTCTTTCACACGTTG R 453 Matte et al.; E1 Tor or
O139b,c
tcpI TAGCCTTAGTTCTCAGCAGGCA F 862 Matte et al.b
GGCAATAGTGTCGAGCTCGTTA
hlyA GGCAAACAGCGAAACAAATACC F 738 Matte et al.; classical
GAGCCGGCATTCATCTGAAT F 481 Matte et al.; nonclassicalb,c
CTCAGCGGGCTAATACGGTTTA R
toxR CCTTCGATCCCCTAAGCAATAC F 779 Matte et al.b
AGGGTTAGCAACGATGCGTAAG R
a F, forward; R, reverse. p
b Matte et al., submitted.
c Biotype- and/or serotype-specific amplification occurs.
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the O1 serogroup strains and most of the O139 serogroup
strains yielded identical fingerprint patterns, regardless of
source of isolation; the only exception was O139 strain CO594,
which produced a closely related PCR profile. Two isolates of
serogroup O139, one clinical isolate (VO16) and one environ-
mental isolate (VO20), did not group with the large O1-O139
group. However, non-cholera-toxigenic O1 and O139 strains
could not be differentiated from their toxigenic counterparts
based on BOX-PCR fingerprints. Like the ERIC-PCR results,
when clinical and environmental V. cholerae non-O1, non-
O139 strains were examined, strains VO22 and VO25, strains
VO23 and VO27, and strains VO24 and VO28 also produced
different but closely related PCR profiles.
AFLP fragment analysis of V. cholerae non-O1, non-O139
strains and of O1 and O139 strains revealed that the band
patterns of the non-O1, non-O139 strains tended to be more
diverse, regardless of the source of isolation, while the patterns
of the O1 and O139 strains were conserved (Fig. 3). However,
differences in the band pattern were detected within and be-
tween the O1 and O139 serogroups.
The PFGE profiles of the V. cholerae strains obtained with
SfiI showed a variety of patterns. For example, clinical and
environmental serogroup O1 isolates had similar restriction
patterns. Similarly, strains of V. cholerae O139, whether clinical
or environmental, displayed different but closely related re-
striction profiles (Fig. 4a). Non-cholera-toxigenic O1 and O139
strains were distinguishable from their toxigenic counterparts
by the fingerprints obtained from SfiI-digested genomic DNA.
The PFGE profiles of non-O1, non-O139 strains differed from
each other and from the patterns displayed by the strains
belonging to the O1 and O139 serogroups. However, two non-
O1, non-O139 isolates, a clinical isolate (VO22) and an envi-
ronmental isolate (VO25), displayed closely related restriction
fingerprint patterns. These data are presented in dendrogram
format in Fig. 4b.
DISCUSSION
Unlike strains of the classical biotype, which are nonhemo-
lytic, strains of the El Tor biotype produce and secrete a he-
molysin into the culture medium. Historically, this feature has
been used to distinguish the two biotypes. However, hemolytic
activity does not always correlate with El Tor biotype, and
many El Tor strains that do not produce hemolysin have been
reported (6, 18, 58). The results of this study also indicate that
a few strains of O1 biotype El Tor and O139, which were
TABLE 3. Selected characteristics of V. cholerae O1, O139, and non-O1, non-O139 strains included in this study
Strain Hemolysis
Presence of the following genes as determined by PCR NCT
productionbctxA zot ace st hlyAa tcpA ompU tcpI toxR
V. cholerae O1 biotype E1 Tor
strains
VO1 Beta 2 2 2 2 1 1 1 1 1 NTc
VO2 Beta 1 1 1 2 1 1 1 1 1 NT
VO13 Beta 1 1 1 2 1 1 1 1 1 NT
VO3 None 1 2 1 2 1 1 1 1 1 NT
VO4 Beta 1 1 1 2 1 1 1 1 1 NT
VO5 None 1 1 1 2 1 1 1 1 1 NT
VO7 Beta 1 1 1 2 1 1 1 1 1 NT
V. cholerae O139 strains
MO45d Beta 1 1 1 2 1 1 1 1 1 NT
CO594 None 1 1 1 2 1 1 1 1 1 NT
CO766 Beta 1 1 1 2 1 1 1 1 1 NT
CO788 Beta 2 2 2 2 1 1 1 1 1 NT
VO12 Beta 1 1 1 2 1 1 1 1 1 NT
VO14 Beta 1 1 1 2 1 1 1 1 1 NT
VO15 Beta 1 1 1 2 1 1 1 1 1 NT
VO16 Beta 1 1 1 2 1 1 1 1 1 NT
VO17 None 1 1 1 2 1 1 1 1 1 NT
VO18 Beta 1 1 1 2 1 1 1 1 1 NT
VO19 Beta 1 1 1 2 1 1 1 1 1 NT
VO20 Beta 1 1 1 2 1 1 1 1 1 NT
V. cholerae non-O1, non-O139
strains
VO22 Beta 2 2 2 2 1 2 2 2 2 1
VO23 Beta 2 2 2 2 2 2 2 2 1 1
VO24 Beta 2 2 2 2 1 2 2 2 1 1
VO25 Beta 2 2 2 2 1 2 2 2 1 1
VO26 Beta 2 2 2 2 1 2 1 2 1 1
VO27 Beta 2 2 2 2 1 2 2 2 1 1
VO28 Beta 2 2 2 2 2 2 2 2 1 1
a Specific for V. cholerae classical hlyA. All V. cholerae strains were positive for nonclassical specific hlyA.
b NCT, new cholera toxin detected by immunodiffusion assay.
c NT, not tested.
d Reference strain MO45 (5 ATCC 51394).
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isolated from diarrheal and environmental samples, did not
show hemolysis in initial tests but were hemolytic on 5% sheep
blood nutrient agar plates after serial passage through rabbit
ileal loops (data not shown). All strains, whether hemolytic or
nonhemolytic on 5% sheep blood nutrient agar plates, were
positive for the hlyA gene as determined by PCR. Thus, it is
clear that sequences homologous to the hemolysin gene are
present in both hemolytic and nonhemolytic strains of V. chol-
FIG. 1. (a) DNA fingerprints of clinical and environmental isolates of V. cholerae O1, O139, and non-O1, non-O139 strains generated by
ERIC-PCR amplification. Lanes M, 1-kb molecular weight ladder; lanes 1 to 3 and 12, O1 strains VO1, VO2, VO3, and VO13, respectively; lanes
4 to 6, O1 strains VO4, VO5, and VO7, respectively; lanes 7 to 11 and 13 to 15, O139 strains MO45 (5 ATCC 51394), CO594, CO766, CO788,
VO12, VO14, VO15, and VO16, respectively; lanes 16 to 19, O139 strains VO17, VO18, VO19, and VO20, respectively; lanes 20 and 21, non-O1,
non-O139 strains VO22, and VO23, respectively; lanes 22 to 26, non-O1, non-O139 strains VO24, VO25, VO26, VO27, and VO28, respectively.
(b) Digitized ERIC-PCR profiles obtained from genomic DNA of clinical and environmental V. cholerae O1, O139, and non-O1, non-O139
isolates. The dendrogram was constructed by using the Molecular Fingerprinting Analyst (Bio-Rad) software with a simple-match similarity matrix,
and data were clustered by the unweighted pair group method with arithmetic means.
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erae O1 biotype El Tor and O139 but may not be expressed in
the nonhemolytic isolates.
The hemolysin produced by V. cholerae non-O1, non-O139
strains is identical to the El Tor hemolysin (78) and is consid-
ered to be a virulence factor that causes diarrhea (2, 35).
However, we found that an El Tor-like hemolysin is not re-
sponsible for fluid production in the rabbit gut, because the
nonhemolytic strains of V. cholerae also cause fluid accumula-
tion. Furthermore, a number of hemolytic strains did not elicit
a secretory response in the initial experiments (68, 71). All V.
FIG. 2. (a) BOX-PCR profiles obtained by using DNA from clinical and environmental V. cholerae O1, O139, and non-O1, non-O139 isolates.
Lanes M, 1-kb molecular weight ladder; lanes 1 to 3 and 12, O1 strains VO1, VO2, VO3, and VO13, respectively; lanes 4 to 6, O1 strains VO4,
VO5, and VO7, respectively; lanes 7 to 11 and 13 to 15, O139 strains MO45 (5 ATCC 51394), CO594, CO766, CO788, VO12, VO14, VO15, and
VO16, respectively; lanes 16 to 19, O139 strains VO17, VO18, VO19, and VO20, respectively; lanes 20 and 21, non-O1, non-O139 strains VO22,
and VO23, respectively; lanes 22 to 26, non-O1, non-O139 strains VO24, VO25, VO26, VO27, and VO28, respectively. (b) Digitized fingerprints
of clinical and environmental V. cholerae O1, O139, and non-O1, non-O139 isolates generated by BOX-PCR amplification. The dendrogram was
constructed by using the Molecular Fingerprinting Analyst (Bio-Rad) software as described in the legend to Fig. 1.
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cholerae non-O1, non-O139 strains examined in this study were
hemolytic on 5% sheep blood nutrient agar and had the ge-
netic potential to produce hemolysin. However, the majority of
the strains did not show a secretory response in initial tests,
strongly suggesting that hemolysin does not play a role in
initiating the secretory response.
The V. cholerae O1 biotype El Tor and O139 strains isolated
from both diarrheal and environmental samples were charac-
terized in detail to obtain an understanding of the role of the
virulence traits in cholera. The environmental isolates, like the
clinical isolates, were positive for ctxA, zot, ace, tcpA, and
ompU amplicons, indicating that the genes comprising the
virulence gene cassette and the genes encoding surface or-
ganelles required for intestinal adherence and colonization
were intact. Thus, both the O1 biotype El Tor strains and the
O139 strains retained the core of the CTX genetic element and
also TCP and OMP both of which are recognized as important
components in pathogenicity, even in the aquatic environment.
These observations are in contrast to reports indicating that
environmental isolates of V. cholerae O1 biotype El Tor are
nontoxigenic (57) and that the hemolysin produced is most
likely responsible for the enterotoxic activity (2, 35).
It is known that some V. cholerae non-O1, non-O139 strains
have the ability to cause diarrhea-like symptoms. Recently,
several localized outbreaks caused by V. cholerae non-O1, non-
O139 have been reported (5, 16, 26, 64). Although some of
these strains produce cholera or cholera-like toxin, the major-
ity lack the virulence gene cassette but produce several other
extracellular products, such as NAG-specific heat-stable toxin,
a thermostable direct hemolysin, Shiga-like toxin, and hemag-
glutinin, which play some role in the disease process (3, 5, 23,
28, 54, 79).
We concluded from results of this study that in the absence
of cholera toxin, NAG-specific heat-stable toxin, and/or TCP
and OMP, V. cholerae O1, O139, and non-O1, non-O139
strains that have clinical or environmental origins have the
ability to cause diarrhea by a mechanism entirely different from
that of the toxigenic V. cholerae O1 and O139 strains. When
culture filtrates from all of the non-cholera-toxigenic V. chol-
erae strains grown in AKI medium (39), mimicking hemolysin
(59), were examined in rabbit guts, they caused fluid accumu-
lation. The non-O1, non-O139 strains examined produced an
enterotoxin that was antigenetically identifiable as a new V.
cholerae toxin. This conclusion is supported by the fact that
enterotoxic activity was completely neutralized (67) by the
previously reported new cholera toxin antiserum (62, 63).
Thus, we concluded that a new secretogenic toxin is the factor
most likely responsible for enterotoxic activity in non-cholera-
toxin-producing V. cholerae O1, O139, and non-O1, non-O139
strains.
Four different genetic fingerprinting methods, ERIC-PCR,
BOX-PCR, AFLP analysis, and PFGE, were used to measure
the relatedness of V. cholerae strains isolated from both clinical
and environmental sources and the relatedness of O1 biotype
FIG. 3. Digitized images of AFLP patterns obtained from ApaI-TaqI template DNA by using the selective PCR primers A01 and T01 for
clinical and environmental V. cholerae O1, O139, and non-O1, non-O139 isolates. The dendrogram was constructed by using the Molecular
Fingerprinting Analyst (Bio-Rad) software as described in the legend to Fig. 1.
VOL. 67, 2001 MOLECULAR ANALYSIS OF V. CHOLERAE 917
El Tor, O139, and non-O1, non-O139 strains. Overall, the
correlation of the results of all methods was excellent, and
strains belonging to O1 biotype El Tor and O139 yielded fin-
gerprint patterns that were closely related but distinct from
those of the non-O1, non-O139 strains. The observed differ-
ences in the band patterns within and between the O1 and
O139 serogroups suggested that there was divergence in
genomic organization which may have arisen from genetic re-
assortment that took place in the environment over time. No
significant difference between the clinical and environmental
FIG. 4. (a) Fingerprint patterns obtained from PFGE of SfiI-digested DNA of clinical and environmental V. cholerae O1, O139, and non-O1,
non-O139 isolates. Lanes M, 1-kb molecular weight ladder; lanes 1 to 3 and 12, O1 strains VO1, VO2, VO3, and VO13, respectively; lanes 4 to
6, O1 strains VO4, VO5, and VO7, respectively; lanes 7 to 11 and 13 to 15, O139 strains MO45 (5 ATCC 51394), CO594, CO766, CO788, VO12,
VO14, VO15, and VO16, respectively; lanes 16 to 19, O139 strains VO17, VO18, VO19, and VO20, respectively; lanes 20, and 21, non-O1,
non-O139 strains VO22, and VO23, respectively; lanes 22 to 26, non-O1, non-O139 strains VO24, VO25, VO26, VO27, and VO28, respectively;
(b) Digitized PFGE analysis of SfiI-digested profiles obtained from genomic DNA of clinical and environmental V. cholerae O1, O139, and non-O1,
non-O139 isolates. The Dendrogram was generated by using the average percentages of matched bands summarizing the degrees of similarity of
the SfiI restriction patterns of genomic DNA of V. cholerae O1, O139, and non-O1, non-O139 strains.
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isolates of V. cholerae was observed. The most interesting find-
ing of the BOX-PCR, AFLP, and PFGE analyses was that
environmental isolates (VO24 and/or VO28) of the non-O1,
non-O139 serogroups were closely related to the toxigenic V.
cholerae O1 and O139 strains.
Collectively, the data indicate that strains of V. cholerae that
cause diarrhea have a clonal origin in the aquatic environment.
Furthermore, clinical V. cholerae strains showed fingerprint
patterns similar to those of strains isolated from the environ-
ment. Although minor differences in band patterns were ob-
served among the strains, we concluded that there is a clonal
relationship between clinical and environmental isolates, which
supports the hypothesis of Colwell et al. (14) that V. cholerae
strains are autochthonous to the aquatic environment and that
aquatic environments serve as multiple reservoirs of toxigenic
and non-cholera-toxigenic V. cholerae strains belonging to the
O1, O139, and non-O1, non-O139 serogroups (12–14, 32, 66).
The first strain of V. cholerae O139 isolated in our laboratory
belonged to the same clone and was isolated in January 1992,
when it was originally isolated from an hydrophytic plant, Eich-
hornia crassipes, in the River Ganga in Varanasi, India; this was
almost 8 months before V. cholerae was isolated from diarrheal
patients in Madras, India.
It has been reported that non-cholera-toxin-producing V.
cholerae non-O1, non-O139 strains possess toxR, the central
regulatory protein gene, and can acquire the tcp gene from
toxigenic V. cholerae O1 by horizontal gene transfer (44) when
they are exposed to the filamentous bacteriophage VPIf. The
ctx element can be acquired by exposure to the toxinoferous
phage CTXf (20, 76). Data obtained in the present study
indicate that there is not a significant difference in the genomic
organizations of toxigenic V. cholerae O1 and O139 strains,
whether they are of clinical or environmental origin. Both
toxigenic V. cholerae O1 strains and non-cholera-toxin-produc-
ing V. cholerae non-O1, non-O139 strains possess toxR, the
central regulatory protein gene, and these strains are present
in the aquatic environment. Thus, it can be hypothesized that
under the selective pressures of the biological and physico-
chemical conditions of the aquatic environment, events like
acquisition of tcp and ctx genetic elements by non-O1, non-
O139 strains from O1 V. cholerae strains can occur after expo-
sure to bacteriophages and thereby favor emergence of a novel
strain. However, given the rare occurrence of non-O1, non-
O139 strains in the environment that possess both the tcpA and
ctx genetic elements (52), it appears that when and if such
events occur, there are attendant changes in the somatic anti-
gen or in the cell surface properties (7, 51). A similar sugges-
tion has recently been made concerning the asd gene se-
quences of O1 and non-O1, non-O139 strains in transition for
the somatic O antigen in V. cholerae (43).
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